Kasper M.A. Rouschop

28.7k citations

67 papers · 4.1k indexed · 2 hit papers · h-index 32

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 19
Cell Biology top 1%
- Endoplasmic Reticulum Stress and Disease 10
- Proteoglycans and glycosaminoglycans research 5
Epidemiology top 2%
- Autophagy in Disease and Therapy 22
Physiology top 1%
- Adipose Tissue and Metabolism 5
Nephrology top 2%
Molecular Biology
- Extracellular vesicles in disease 8
- RNA modifications and cancer 8
- Mitochondrial Function and Pathology 6

Co-authors: Tom G. Keulers Bradly G. Wouters Marco B.E. Schaaf Marc Vooijs Marianne Koritzinsky Sandrine Florquin Philippe Lambin Jan J. Weening
Cited by: Cancer Research Cell Biology Epidemiology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: Netherlands Canada United States

In The Last Decade

Kasper M.A. Rouschop

64 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kasper M.A. Rouschop

Since Specialization

Citations

This map shows the geographic impact of Kasper M.A. Rouschop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasper M.A. Rouschop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasper M.A. Rouschop more than expected).

Fields of papers citing papers by Kasper M.A. Rouschop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasper M.A. Rouschop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasper M.A. Rouschop. The network helps show where Kasper M.A. Rouschop may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kasper M.A. Rouschop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kasper M.A. Rouschop Line = papers co-authored together Kasper M.A. Rouschop links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas Oncogenesis ·Anaís Sánchez‐Castillo,Kim G. Savelkouls,A Baldini,Judith Hounjet,Pierre Sonveaux,Paulien Verstraete,Kim De Keersmaecker,Barbara Dewaele,Benny Björkblom,Beatrice Melin,Wendy Wu,Rickard L. Sjöberg,Kasper M.A. Rouschop,Martijn Broen,Marc Vooijs,Kim R. Kampen	2024	4
2	Cancer EV stimulate endothelial glycolysis to fuel protein synthesis via mTOR and AMPKα activation Journal of Extracellular Vesicles ·Joël E.J. Beaumont,Lydie M.O. Barbeau,Jinzhe Ju,Kim G. Savelkouls,Freek G. Bouwman,Marijke I. Zonneveld,Annelies Bronckaers,Kim R. Kampen,Tom G. Keulers,Kasper M.A. Rouschop	2024	5
3	Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer British Journal of Cancer ·Anaís Sánchez‐Castillo,Elien Heylen,Judith Hounjet,Kim G. Savelkouls,Natasja G. Lieuwes,Rianne Biemans,Ludwig J. Dubois,Kobe Reynders,Kasper M.A. Rouschop,Rianne D.W. Vaes,Kim De Keersmaecker,Maarten Lambrecht,Lizza Hendriks,Dirk K.M. De Ruysscher,Marc Vooijs,Kim R. Kampen	2023	11
4	GABARAPL1 is essential in extracellular vesicle cargo loading and metastasis development Radiotherapy and Oncology ·Joël E.J. Beaumont,Jinzhe Ju,Lydie M.O. Barbeau,Imke Demers,Kim G. Savelkouls,Kasper Derks,Freek G. Bouwman,Marca H. M. Wauben,Marijke I. Zonneveld,Tom G. Keulers,Kasper M.A. Rouschop	2023	4
5	ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer Autophagy ·Tom G. Keulers,Alexander Koch,Marike W. van Gisbergen,Lydie M.O. Barbeau,Marijke I. Zonneveld,Monique C. de Jong,Kim G.M. Savelkouls,Roel G. Wanders,Johan Bussink,Veerle Melotte,Kasper M.A. Rouschop	2021	24
6	The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition Oncogene ·Judith Hounjet,R. Habets,Marco B.E. Schaaf,Tessa C. Hendrickx,Lydie M.O. Barbeau,Sanaz Yahyanejad,Kasper M.A. Rouschop,Arjan J. Groot,Marc Vooijs	2019	23
7	Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey Clinical and Translational Radiation Oncology ·Jean‐Emmanuel Bibault,Pierfrancesco Franco,Gerben R. Borst,Wouter van Elmpt,D. Thorwhart,Maximilian Schmid,Kasper M.A. Rouschop,Mateusz Spałek,L. Mullaney,Kathrine Røe Redalen,Ludwig Dubois,Christine Verfaillie,Jesper Grau Eriksen	2018	32
8	Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy Kidney International ·Elena Rampanelli,Kasper M.A. Rouschop,Nike Claessen,Gwendoline J.D. Teske,Steven T. Pals,Jaklien C. Leemans,Sandrine Florquin	2014	15
9	Hypoxic Activation of the PERK/eIF2α Arm of the Unfolded Protein Response Promotes Metastasis through Induction of LAMP3 Clinical Cancer Research ·Hilda Mujčić,Anika Nagelkerke,Kasper M.A. Rouschop,Stephen W. Chung,Naz Chaudary,Paul N. Span,Blaise Clarke,Michael Milosevic,Jenna Sykes,Rićhard P. Hill,Marianne Koritzinsky,Bradly G. Wouters	2013	106
10	Autophagy is required during cycling hypoxia to lower production of reactive oxygen species Radiotherapy and Oncology ·Kasper M.A. Rouschop,Chantal H.M.A. Ramaekers,Marco B.E. Schaaf,Tom G. Keulers,Kim G.M. Savelkouls,Philippe Lambin,Marianne Koritzinsky,Bradly G. Wouters	2009	113
11	Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 Radiotherapy and Oncology ·Hilda Mujčić,Tomasz Rzymski,Kasper M.A. Rouschop,Marianne Koritzinsky,Manuela Milani,Adrian L. Harris,Bradly G. Wouters	2009	77
12	Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection Nephrology Dialysis Transplantation ·Joris J. T. H. Roelofs,Kasper M.A. Rouschop,Gwendoline J.D. Teske,Gerry T. M. Wagenaar,Nike Claessen,Jan J. Weening,Tom van der Poll,Sandrine Florquin	2008	8
13	Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress Radiotherapy and Oncology ·Michaël G. Magagnin,Kjell Sergeant,Twan van den Beucken,Kasper M.A. Rouschop,Barry Jutten,Renaud Seigneuric,Philippe Lambin,Bart Devreese,Marianne Koritzinsky,Bradly G. Wouters	2007	16
14	Impact of supervised gene signatures of early hypoxia on patient survival Radiotherapy and Oncology ·Renaud Seigneuric,Maud H. W. Starmans,Glenn Fung,Balaji Krishnapuram,Dimitry S.A. Nuyten,Arie van Erk,Michaël G. Magagnin,Kasper M.A. Rouschop,Sriram Krishnan,R. Bharat Rao,Chris T. Evelo,Adrian C. Begg,Bradly G. Wouters,Philippe Lambin	2007	48
15	Urothelial CD44 Facilitates Escherichia coli Infection of the Murine Urinary Tract The Journal of Immunology ·Kasper M.A. Rouschop,Marc Sylva,Gwendoline J.D. Teske,Inge Hoedemaeker,Steven T. Pals,Jan J. Weening,Tom van der Poll,Sandrine Florquin	2006	40
16	Renal expression of CD44 correlates with acute renal allograft rejection Kidney International ·Kasper M.A. Rouschop,Joris J. T. H. Roelofs,Marc Sylva,Ajda T. Rowshani,Ineke J. M. ten Berge,Jan J. Weening,Sandrine Florquin	2006	31
17	CD44 Disruption Prevents Degeneration of the Capillary Network in Obstructive Nephropathy via Reduction of TGF-β1–Induced Apoptosis Journal of the American Society of Nephrology ·Kasper M.A. Rouschop,Nike Claessen,Steven T. Pals,Jan J. Weening,Sandrine Florquin	2006	33
18	The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritis Kidney International ·Joris J. T. H. Roelofs,Kasper M.A. Rouschop,Gwendoline J.D. Teske,Nike Claessen,Jan J. Weening,Tom van der Poll,Sandrine Florquin	2006	25
19	CD44 Deficiency Increases Tubular Damage But Reduces Renal Fibrosis in Obstructive Nephropathy Journal of the American Society of Nephrology ·Kasper M.A. Rouschop,Miguel E. Sewnath,Nike Claessen,Joris J. T. H. Roelofs,Inge Hoedemaeker,Ronald van der Neut,Jan Aten,Steven T. Pals,Jan J. Weening,Sandrine Florquin	2004	97
20	Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44? Kidney International ·Sandrine Florquin,Kasper M.A. Rouschop	2003	22

About Kasper M.A. Rouschop

Kasper M.A. Rouschop is a scholar working on Cancer Research, Cell Biology and Epidemiology, having authored 67 papers that have together received 4.1k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (22 papers), Cancer, Hypoxia, and Metabolism (19 papers), Endoplasmic Reticulum Stress and Disease (10 papers), Extracellular vesicles in disease (8 papers), RNA modifications and cancer (8 papers), Mitochondrial Function and Pathology (6 papers), Proteoglycans and glycosaminoglycans research (5 papers) and Adipose Tissue and Metabolism (5 papers). The work is most often cited by research in Cancer Research (918 citations), Cell Biology (862 citations) and Epidemiology (1.5k citations). Kasper M.A. Rouschop has collaborated with scholars based in Netherlands, Canada and United States. Frequent co-authors include Tom G. Keulers, Bradly G. Wouters, Marco B.E. Schaaf, Marc Vooijs, Marianne Koritzinsky, Sandrine Florquin, Philippe Lambin, Jan J. Weening, Nike Claessen and Johan Bussink. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact